Muscle striation antibodies in myasthenia gravis - Diagnostic and functional significance

Annals of the New York Academy of Sciences

Volumn 841, Issue , 1998, Pages 505-515

  Aarli, Johan A ^a   Skeie, Geir Olve ^a   Mygland, Åse ^a   Gilhus, Nils Erik ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CITRIC ACID; CONNECTIN; EPITOPE; HEART ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; MESSENGER RNA; MUSCLE ANTIBODY; MUSCLE ANTIGEN; RYANODINE; RYANODINE RECEPTOR;

CONFERENCE PAPER; DIAGNOSTIC VALUE; DISEASE SEVERITY; EPITHELIUM CELL; HUMAN; MESSENGER RNA SYNTHESIS; MYASTHENIA GRAVIS; PATHOGENESIS; RECEPTOR AFFINITY; SARCOMERE; SARCOPLASMIC RETICULUM; SKELETAL MUSCLE; THYMOMA; THYMUS;

EID: 0031927285     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb10971.x     Document Type: Article

References (51)

1. STRAUSS, A. J. L., B. SEEGAL, J. C. HSU, P. M. BURKHOLDER, W. NASTUK & K. E. OSSERMAN. 1960. Immunofluorescence demonstration of a muscle binding, complement fixing serum globulin fraction in myasthenia gravis. Proc. Soc. Exp. Biol. 1195: 184-191.
2. BEUTNER, E. H., E. WITEBSKY, D. RICKEN & R. H. ADLER. 1962. Studies on autoantibodies in myasthenia gravis. JAMA 182: 46-58.
3. VAN DER GELD, H. & A. J. L. STRAUSS. 1966. Myasthenia gravis: immunological relationship between striated muscle and thymus. Lancet i: 57-60.
4. VETTERS, J. M. 1965. Immunofluorescence staining patterns in skeletal muscle using the serum of myasthenic patients and normal controls. Immunology 9: 93-95.
5. VETTERS, J. M. 1967. Muscle antibodies in myasthenia gravis. Immunology 13: 275-280.
6. AARLI, J. A. & O. CLOSS. 1972. Myasthenia gravis: cross-striational fluorescence of muscle fibers mediated by Fc fragments. J. Immunol. 109: 271-274.
7. PATRICK, J. & J. LINDSTROM. 1973. Autoimmune response to acetylcholine receptors. Science 180: 871-872.
8. AARLI, J. A. 1972. Myasthenia gravis: antibodies to an acid-soluble muscle antigen reacting with antibodies in myasthenia gravis sera. Acta Pathol. Microbiol. Scand. Sect. B 80: 453-459.
9. AARLI, J. A., N. E. GILHUS & H. HOFSTAD. 1987. CA-antibody: an immunological marker of thymic neoplasia in myasthenia gravis? Acta Neurol. Scand. 63: 55-57.
10. WILLIAMS, C. L. & V. A. LENNON. 1986. Thymic B-lymphocyte clones from patients with myasthenia gravis secrete monoclonal striational autoantibodies reacting with myosin, α-actinin, or actin. J. Exp. Med. 164: 1043-1059.
11. OHTA, M., K. OHTA, N. ITOH, M. KURODE, K. HAYASHI & H. NISHITANI. 1990. Anti-skeletal muscle antibodies in the sera from myasthenic patients with thymoma: identification of anti-myosin, actomyosin, actin, and α-actinin antibodies by a solid-phase radioimmunoassay and a Western blotting analysis. Clin. Chim. Acta 187: 255-264.
12. AARLI, J. A., K. STEFANSSON, L. S. G. MARTON & R. WOLLMANN. 1990. Patients with myasthenia gravis and thymoma have in their sera IgG autoantibodies against titin. Clin. Exp. Immunol. 82: 284-288.
13. FÜRST, D. O., R. NAVE, M. OSBORN & K. WEBER. 1989. Repetitive titin epitopes with a 42-nm spacing coincide in relative major myosin-associated proteins: an immunoelectron-microscopical study on myofibrils. J. Cell Sci. 94: 119-125.
14. FÜRST, D. O., M. OSBORN, R. NAVE & K. WEBER. 1988. The organization of titin filaments in the half-sarcomere revealed by monoclonal antibodies in immunoelectron microscopy: a map often nonrepetitive epitopes starting at the Z line extends close to the M line. J. Cell Biol. 106: 1563-1572.
15. MARUYAMA, K., S. MATSUBARA, R. NATORI, Y. NONOMURA, S. KIMURA, K. OHASHI, F. MURAKAMI, S. HANDA & G. EGUCHI. 1977. Connectin, an elastic protein of muscle: characterization and function. J. Biochem. (Tokyo) 82: 317-337.
16. LABEIT, S. & B. KOLMERER. 1995. Titins: giant proteins in charge of muscle ultrastructure and elasticity. Science 270: 293-296.
17. FULTON, A. B. & W. B. ISAACS. 1991. Titin, a huge, elastic sarcomeric protein with a probable role in morphogenesis. Bioessays 13: 157-161.
18. GAUTEL, M., A. LAKEY, D. P. BARLOW, Z. HOLMES, S. SCALES, K. LEONARD, S. LABEIT, Å. MYGLAND, N. E. GILHUS & J. A. AARLI. 1993. Titin antibodies in myasthenia gravis: identification of a major immunogenic region of titin. Neurology 43: 1581-1585.
19. LABEIT, S., B. KOLMERER & W. A. LINKE. 1997. The giant protein titin: emerging roles in physiology and pathophysiology. Circ. Res. 80: 290-294.
20. LINKE, W. A., M. IVEMEYER, N. OLIVIERI, B. KOLMERER, J. C. RÜEGG & S. LABEIT. 1996. Towards a molecular understanding of the elasticity of titin. J. Mol. Biol. 261: 62-71.
21. LÜBKE, E., A. FREIBURG, G. O. SKEIE, B. KOLMERER, S. LABEIT, J. A. AARLI, N. E. GILHUS, R. WOLLMANN, M. WÜSSLING, J. RÜEGG & W. A. LINKE. 1997. Striational autoantibodies in myasthenia gravis: evidence for titin epitope spreading. Submitted.
22. MARX, A., M. OSBORN, S. TZARTOS, K. I. GEUDER, B. SCHALKE, W. NIX, T. KIRCHNER & H. K. MÜLLER-HERMELINK. 1992. A Striational muscle antigen and myasthenia gravis associated thymomas share an acetylcholine-receptor epitope. Dev. Immunol. 2: 77-84.
23. GILHUS, N. E., J. A. AARLI, B. CHRISTENSSON & R. MATRE. 1984. Rabbit antiserum to a citric acid extract of human skeletal muscle staining thymoma from myasthenia gravis patients. J. Neuroimmunol. 7: 55-64.
24. DARDENNE, M., W. SAVINO & J. F. BACH. 1987. Thymomatous epithelial cells and skeletal muscle share a common epitope defined by a monoclonal antibody. Am. J. Pathol. 126: 194-198.
25. KIRCHNER, T., S. TZARTOS, F. HOPPE, B. SCHALKE, H. WEKERLE & H. K. MÜLLER-HERMELINK. 1988. Pathogenesis of myasthenia gravis: acetylcholine receptor-related antigenic determinants in tumor-free thymuses and thymic epithelial tumors. Am. J. Pathol. 130: 268-280.
26. MARX, A., A. WILISCH, A. SCHULTZ, A. GREINER, B. MAGI, V. PALLINI, B. SCHALKE, K. TOYKA, W. NIX, T. KIRCHNER & H. K. MÜLLER-HERMELINK. 1996. Expression of neurofilaments and of a titin epitope in thymic epithelial tumors. Am. J. Pathol. 148: 1839-1850.
27. SKEIE, G. O., A. FREIBURG, B. KOLMERER, S. LABEIT, J. A. AARLI, S. A. APPIAH-BOADU & N. E. GILHUS. 1997. Titin transcripts in thymomas. Submitted.
28. WILLCOX, N. 1993. Myasthenia gravis. Curr. Opin. Immunol. 5: 910-917.
29. MARX, A., D. SCHOMIG, A. SCHULTZ, S. GATTENLOHNER, A. JUNG, A. MELMS & H. K. MÜLLER-HERMELINK. 1994. Distribution of molecules mediating thymocyte-stroma-interactions in human thymus, thymitis, and thymic epithelial tumors. Thymus 23: 83-89.
30. AARLI, J. A., N. E. GILHUS & R. MATRE. 1992. Myasthenia gravis with thymoma is not associated with an increase of other autoimmune disorders. Autoimmunity 11: 159-162.
31. GILHUS, N. E., N. WILLCOX, G. HARCOURT, N. NAGVEJAR, D. BEESON, A. VINCENT & J. NEWSOM-DAVIS. 1995. Antigen presentation by thymoma epithelial cells from myasthenia gravis patients to potentially pathogenic T cells. J. Neuroimmunol. 56: 65-76.
32. SKEIE, G. O., J. A. AARLI, R. MATRE, A. FREIBURG & N. E. GILHUS. 1997. Titin antibody positive myasthenia gravis patients have a cellular immune response against the main immunogenic region of thin. Eur. J. Neurol. 4: 1-7.
33. PESCARMONA, E., S. ROSATI, A. PISACANE, E. A. RENDINA, F. VENUTA & C. D. BARONI. 1992. Microscopic thymoma: histological evidence of multifocal cortical and medullary origin. Histopathology 20: 263-266.
34. LANSKA, D. J. 1991. Diagnosis of thymoma in myasthenics using anti-striated muscle antibodies: predictive value and gain in diagnostic certainty. Neurology 41: 520-524.
35. SKEIE, G. O., Å. MYGLAND, J. A. AARLI & N. E. GILHUS. 1995. Titin antibodies in patients with late onset myasthenia gravis: clinical correlations. Autoimmunity 20: 99-104.
36. MCFARLIN, D. E., M. BARLOW & A. J. L. STRAUSS. 1966. Antibodies to muscle and thymus in nonmyasthenic patients with thymoma. N. Engl. J. Med. 275: 1321-1326.
37. ROWLAND, L. P., H. ARANOW, JR. & P. F. A. HOEFER. 1957. Myasthenia gravis appearing after removal of a thymoma. Neurology 7: 584-588.
38. GILHUS, N. E., J. A. AARLI, R. W. C. JANZEN & R. MATRE. 1985. Skeletal muscle antibodies in patients with a thymoma, but without myasthenia gravis, J. Neuroimmunol. 8: 69-78.
39. KUKS, J. B. M. 1992. The Thymus and Myasthenia Gravis. Drukkerij Regenboog. Groningen.
40. PERLO, V. P., B. ARNASON & B. CASTLEMAN. 1975. The thymus gland in elderly patients with myasthenia gravis. Neurology 25: 294-295.
41. KEYNES, G. 1946. The surgery of the thymus gland. Br. J. Surg. 33: 201-214.
42. OOSTERHUIS, H. J. 1981. Observations of the natural history of myasthenia gravis and effect of therapeutic measures. Ann. N.Y. Acad. Sci. 377: 678-689.
43. SOMNIER, F. & W. TROJABURG. 1993. Neurophysiological evaluation in myasthenia gravis: a comprehensive study of a complete patient population. Electroencephalogr. Clin. Neurophysiol. 89: 73-87.
44. GROSS, W. L., W. H. SCHMITT & E. CSERKOK. 1992. ANCA and associated diseases: immunodiagnostic and pathogenetic aspects. Clin. Exp. Immunol. 91: 1-12.
45. MA, J., N. KING, C. L. CHEN, R. PENNY & S. N. BREIT. 1993. Antibody penetration of viable human cells. II. Anti-RNP antibodies binding to RNP antigen expressed on cell surface, which may mediate the antibody internalization. Clin. Exp. Immunol. 93: 396-404.
46. MYGLAND, Å., O. B. TYSNES, J. A. AARLI, P. R. FLOOD & N. E. GILHUS. 1992. Myasthenia gravis patients with a thymoma have antibodies against a high molecular weight protein in sarcoplasmic reticulum. J. Neuroimmunol. 37: 1-7.
47. TAKESHIMA, H., I. MASAMITSU, H. TAKEKURA, N. MIYUKI, J. KUNU, O. MINOWA, H. TAKANO & T. NODA. 1994. Excitation-contraction uncoupling in mice lacking functional skeletal muscle ryanodine-receptor gene. Nature 369: 556-559.
48. MENDELL, J. R., J. N. WHITAKER & W. K. ENGEL. 1973. The skeletal muscle binding site of antistriated muscle antibody in myasthenia gravis: an electron microscopic immunohistochemical study using peroxidase conjugated antibody fragments. J. Immunol. 111: 847-856.
49. MYGLAND, Å., O. B. TYSNES, R. MATRE, P. VOLPE, J. A. AARLI & N. E. GILHUS. 1992. Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma. Ann. Neurol. 32: 589-591.
50. MYGLAND, Å., J. A. AARLI, R. MATRE & N. E. GILHUS. 1994. Ryanodine receptor autoantibodies related to the severity of thymoma associated myasthenia gravis. J. Neurol. Neurosurg. Psychiatry 57: 843-846.
51. 3H]-ryanodine to sarcoplasmic reticulum. Submitted.